Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: Synthesis, structure, electrochemistry, and cytotoxicity

Inorganic Chemistry

Volumn 47, Issue 2, 2008, Pages 578-583

  Auzias, Mathieu ^a   Therrien, Bruno ^a   Süss Fink, Georg ^a   Štěpnička, Petr ^b   Wee, Han Ang ^c   Dyson, Paul J ^c  

^a UNIVERSITY OF NEUCHÂTEL   (Switzerland)

^b CHARLES UNIVERSITY   (Czech Republic)

^c EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FERROCENE; FERROUS ION; PYRIDINE; PYRIDINE DERIVATIVE; RUTHENIUM DERIVATIVE;

ARTICLE; CHEMISTRY; ELECTROCHEMISTRY; FEMALE; HUMAN; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; ELECTROCHEMISTRY; FEMALE; FERROUS COMPOUNDS; HUMANS; PYRIDINES; RUTHENIUM COMPOUNDS;

EID: 38949087862     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic7018742     Document Type: Article

References (57)

1. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222, 385-386.
2. (a) Reedijk, J. Chem. Commun. 1996, 7, 801-806.
3. (b) Wong, E.; Giandomenico, C. M. Chem. Rev. 1999, 99, 2451-2461 and references cited therein.
4. (c) Boulikas, T.; Vougiouka, M. Oncol. Rep. 2003, 10, 1663-1682.
5. (a) Chu, G. J. Biol. Chem. 1994, 269, 787-790.
6. (b) Fuertes, M. A.; Alonso, C.; Perez, J. M. Chem. Rev. 2003, 103, 645-662.
7. (c) Agarwal, R.; Kaye, S. B. Nat. Rev. Cancer 2003, 3, 502-516.
8. Wang, D.; Lippard, S. J. Nat. Rev. Drug Discov. 2005, 4, 307-320.
9. Köpf-Maier, P.; Köpf, H. Chem. Rev. 1987, 87, 1137-1152.
10. Kröger, N.; Kleeberg, U. R.; Mross, K.; Edler, L.; Sass, G.; Hossfeld, D. K. Onkologie 2000, 23, 60-62.
11. Carso, F.; Rossi, M. Mini-Rev. Med. Chem. 2004, 4, 49-60.
12. Top, S.; Vessières, A.; Cabestaing, C.; Laios, I.; Leclercq, G.; Provot, C.; Jaouen, G. J. Organomet. Chem. 2001, 637-639, 500-506.
13. Sava, G.; Bergamo, A. Int. J. Oncol. 2000, 17, 353-365.
14. Rademaker-Lakhai, J. M.; Van den Bongard, D.; Pluim, D.; Beijnen, J. H.; Schellens, J. H. Clin. Cancer Res. 2004, 10, 3717-3727.
15. (a) Sava, G.; Gagliardi, R.; Bergamo, A.; Alessio, E.; Mestroni, G. Anticancer Res. 1999, 19, 969-972.
16. (b) Bergamo, A.; Gava, B.; Alessio, E.; Mestroni, G.; Serli, B.; Cocchieto, M.; Zorzet, S.; Sava, G. Int. J. Oncol. 2002, 21, 1331-1338.
17. (c) Groessl, M.; Reisner, E.; Hartinger, C. G.; Eichinger, R.; Semenova, O.; Timerbaev, A. R.; Jakupec, M. A.; Arion, V. B.; Keppler, B. K. J. Med. Chem. 2007, 50, 2185-2193.
18. (a) Hartinger, C. G.; Zorbas-Seifried, S.; Jakupec, M. A.; Kynast, B.; Zorbas, H.; Keppler, B. K. J. Inorg. Biochem. 2006, 100, 894-904.
19. (b) Kapitza, S.; Pongratz, M.; Jakupec, M. A.; Heffeter, P.; Berger, W.; Lackinger, L.; Keppler, B. K.; Marian, B. J. Cancer Res. Clin. Oncol. 2005, 131, 101-110.
20. (c) Keppler, B. K.; Henn, M.; Juhl, U. M.; Berger, M. R.; Niebl, R.; Wagner, F. E. Prag. Clin. Biochem. Med. 1989, 10, 41-69.
21. (d) Pongratz, M.; Schluga, P.; Jakupec, M. A.; Arion, V. B.; Hartinger, C. G.; Allmaier, G.; Keppler, B. K. J. Anal. At. Spectrom. 2004, 19, 46-51.
22. Kreuser, E. D.; Keppler, B. K.; Berdel, W. E.; Piest, A.; Thiel, E. Semin. Oncol. 1992, 19, 73-81.
23. (a) Pigeon, P.; Top, S.; Vessières, A.; Huché, M.; Hillard, E. A.; Salomon, E.; Jaouen, G. J. Med. Chem. 2005, 48, 2814-2821.
24. (b) Vessières, A.; Top, S.; Beck, W.; Hillard, E.; Jaouen, G. Dalton Trans. 2006, 529-541.
25. Ang, W. H.; Dyson, P. J. Eur. J. Inorg. Chem. 2006, 4003-4018.
26. (a) Popova, L. V.; Babin, V. N.; Belousov, Y. A.; Nekrasov, Y. S.; Snegireva, A. E.; Borodina, N. P.; Shaposhnikova, G. M.; Bychenko, O. B.; Raevskii, P. M. Appl. Organomet. Chem. 1993, 7, 85-94.
27. (b) Köpf-Maier, P.; Köpf, H.; Neuse, E. W. J. Cancer Res. Clin. 1984, 108, 336-340.
28. Hillard, E.; Vessieres, A.; Le Bideau, F.; Plażuk, D.; Spera, D.; Huché, M.; Jaouen, G. Chem. Med. Chem. 2006, 1, 551-559 and references cited therein.
29. Henderson, W.; Alley, S. R. Inorg. Chim. Acta 2001, 322, 106-112.
30. Rosenfeld, A.; Blum, J.; Gibson, D.; Ramu, A. Inorg. Chim. Acta 1992, 201, 219-221.
31. Viotte, M.; Gautheron, B.; Kubicki, M. M.; Nifant'ev, I. E.; Fricker, S. P. Met.-Based Drugs 1995, 2, 311-326.
32. (a) Messori, L.; Gonzales Vilchez, F.; Vilaplana, R.; Piccioli, F.; Alessio, E.; Keppler, B. Met.-Based Drugs 2000, 7, 335-342.
33. (b) Timerbaev, A. R.; Hartinger, C. G.; Aleksenko, S. S.; Keppler, B. K. Chem. Rev. 2006, 106, 2224-2248.
34. (c) Hartinger, C. G.; Ang, W. H.; Casini, A.; Messori, L.; Keppler, B. K.; Dyson, P. J. J. Anal. At. Spectrom. 2007, 22, 960-967.
35. (d) Polec-Pawlak, K.; Abramski, J. K.; Semenova, O.; Hartinger, C. G.; Timerbaev, A. R.; Keppler, B. K.; Jarosz, M. Electrophoresis 2006, 27, 1128-1135.
36. (e) Clarke, M. J.; Bitler, S.; Rennen, D.; Buchbinder, M.; Kelman, A. D. J. Inorg. Biochem. 1980, 12, 79-87.
37. (f) Schluga, P.; Hartinger, C. G.; Egger, A.; Reisner, E.; Galanski, M.; Jakupec, M. A.; Keppler, B. K. Dalton Trans. 2006, 14, 1796-1802.
38. Dyson, P. J.; Sava, G. Dalton Trans. 2006, 1929-1933.
39. Dale, L. D.; Tocher, J. H.; Dyson, T. M.; Edwards, D. I.; Tocher, D. A. Anti-Cancer Drug Des. 1992, 7, 3-14.
40. Allardyce, C. S.; Dyson, P. J.; Ellis, D. J.; Heath, S. L. Chem. Commun. 2001, 1396-1397.
41. (b) Scolaro, C.; Bergamo, A.; Brescacin, L.; Delfino, R.; Cocchietto, M.; Laurenczy, G.; Geldbach, T. J.; Sava, G.; Dyson, P. J. J. Med. Chem. 2005, 48, 4161-4171.
42. Morris, R. E.; Aird, R. E.; Murdoch, P. D. S.; Chen, H.; Cummings, J.; Hughes, N. D.; Parsons, S.; Parkin, A.; Boyd, G.; Jodrell, D. I.; Sadler, P. J. J. Med. Chem. 2001, 44, 3616-3621.
43. Themen, B.; Ang, W. H.; Chérioux, F.; Vieille-Petit, L.; Juillerat-Jeanneret, L.; Süss-Fink, G.; Dyson, P. J. J. Cluster Sci. 2007, 18, 741-752.
44. Allardyce, C. S.; Dyson, P. J. J. Cluster Sci. 2001, 12, 563-569.
45. (a) Bennett, M. A.; Smith, A. K. J. Chem. Soc., Dalton Trans. 1974, 233-241.
46. (b) Bennett, M. A.; Huang, T.-N.; Matheson, T. W.; Smith, A. K. Inorg. Synth. 1982, 21, 74-76.
47. Auzias, M.; Therrien, B.; Labat, G.; Stoeckli-Evans, H.; Süss-Fink, G. Inorg. Chim. Acta 2006, 359, 1012-1017.
48. Auzias, M.; Therrien, B.; Süss-Fink, G. Inorg. Chem. Commun. 2007, 10, 1239-1243.
49. Steedman, A. J.; Burrell, A. K. Acta Crystallogr. 1997, C53, 864-866.
50. (b) Vock, C. A.; Scolaro, C.; Phillips, A. D.; Scopelitti, R.; Sava, G.; Dyson, P. J. J. Med. Chem. 2006, 49, 5552-5561.
51. lim is the limiting current in voltammetry at Pt-RDE, ν the scan rate, and ω the rotation frequency of the disc electrode.
52. Chen, H.; Parkinson, J. A.; Nováková, O.; Bella, J.; Wang, F.; Dawson, A.; Gould, R.; Parsons, S.; Brabec, V.; Sadler, P. J. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 14623-14628.
53. Reedijk, J.; Lohman, P. H. M. Pharm. World Sci. 1985, 7, 173-180.
54. Masuda, H.; Ozols, R. F.; Lai, G.-M.; Fojo, A.; Rothenberg, M.; Hamilton, T. C. Cancer Res. 1988, 48, 5713-5716.
55. Sheldrick, G. M. SHELXS-97, Program for Crystal Structure Solution; University of Göttingen: Göttingen, Germany, 1997.
56. Sheldrick, G. M. SHELXL-97, Program for Crystal Structure Refinement; University of Göttingen: Göttingen, Germany, 1997.
57. Farrugia, L. J. J. Appl. Crystallogr. 1997, 30, 565.